Cargando…
Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer
Prostate cancer is driven by androgen stimulation of the androgen receptor (AR). The next-generation AR antagonist, enzalutamide, prolongs survival, but resistance and lethal disease eventually prevail. Emerging data suggest that the glucocorticoid receptor (GR) is upregulated in this context, stimu...
Autores principales: | Li, Jianneng, Alyamani, Mohammad, Zhang, Ao, Chang, Kai-Hsiung, Berk, Michael, Li, Zhenfei, Zhu, Ziqi, Petro, Marianne, Magi-Galluzzi, Cristina, Taplin, Mary-Ellen, Garcia, Jorge A, Courtney, Kevin, Klein, Eric A, Sharifi, Nima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5305204/ https://www.ncbi.nlm.nih.gov/pubmed/28191869 http://dx.doi.org/10.7554/eLife.20183 |
Ejemplares similares
-
Redirecting abiraterone metabolism to fine tune prostate cancer anti-androgen therapy
por: Li, Zhenfei, et al.
Publicado: (2016) -
Corporate Takeover Targets
por: Meghouar, Hicham
Publicado: (2016) -
Scientific Illiteracy and the Partisan Takeover of Biology
por: Gross, Liza
Publicado: (2006) -
Viral Takeover of the Host Ubiquitin System
por: Gustin, Jean K., et al.
Publicado: (2011) -
A Mutation Threshold for Cooperative Takeover
por: Champagne-Ruel, Alexandre, et al.
Publicado: (2022)